Enter inventor name

Mohammad Movassaghi

USPTO Granted Patents = 11 (Patent Applications = 5)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 46(Granted Patents)

Location History:

Arlington, MA (US) (2016 - 2020)
Lincoln, MA (US) (2021 - 2024)

Company Filing History:

11 out of 8,375

Massachusetts Institute of Technology

patents

4 out of 2,345

University of Illinois

where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12180228 - Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof (2024-12-31),

2. 12030888 - Himastatin derivatives, and processes of preparation thereof, and uses thereof (2024-07-09),

3. 11932650 - Potent agelastatin derivatives as modulators for cancer invasion and metastasis (2024-03-19),

4. 11535634 - Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof (2022-12-27),

5. 10918735 - Substituted pyrazino[1',2′:1,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment (2021-02-16),

6. 10918627 - Convergent and enantioselective total synthesis of Communesin analogs (2021-02-16),

7. 10640508 - Diazene directed modular synthesis of compounds with quaternary carbon centers (2020-05-05),

8. 10220099 - Substituted pyrazino[1',2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment (2019-03-05),

9. 9962383 - Compounds, compositions and methods of agelastatin alkaloids (2018-05-08),

10. 9434736 - Compounds, compositions and methods of agelastatin alkaloids (2016-09-06),

11. 9353150 - Substituted pyrazino[1',2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment (2016-05-31),

Title: Inventor Spotlight: Mohammad Movassaghi

Introduction

Mohammad Movassaghi is a distinguished inventor based in Arlington, MA, with a remarkable portfolio of 11 patents. His innovative work primarily focuses on chemical compounds, particularly in the area of epipolythiodiketopiperazines and polythiodiketopiperazines, showcasing his contribution to advancements in the field of biomedical research.

Latest Patents

Movassaghi's latest patents include significant innovations. The first patent involves "Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof." This disclosure outlines various compounds, compositions, kits, methods of synthesis, and methods of use involving these compounds.

His second notable patent is titled "Himastatin derivatives, and processes of preparation thereof, and uses thereof," which provides details on compounds of Formula I, methods for their preparation, compositions, kits, and applications geared toward treating or preventing microbial infections.

Career Highlights

During his career, Movassaghi has made significant contributions through his work in reputable institutions such as the Massachusetts Institute of Technology (MIT) and the University of Illinois. His time at these institutions has facilitated groundbreaking research, contributing to the development and application of his patented inventions.

Collaborations

Movassaghi has collaborated with notable peers, including Paul Joseph Hergenrother and Justin Kim. These partnerships highlight the collaborative nature of scientific innovation and have likely played an essential role in the development and success of his patents.

Conclusion

Mohammad Movassaghi exemplifies the spirit of innovation and dedication to scientific advancement. With his extensive patent portfolio and significant contributions to research, he continues to impact the fields of biochemistry and biomedical sciences. His work not only showcases individual brilliance but also underscores the importance of collaboration in pushing the boundaries of invention.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com